B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer
Stucchi, Simone; Borea, Roberto; Garcia-Recio, Susana; Zingarelli, Manuela; Radler, Patrick D.; Camerini, Elena; Pellegry, Caroline Marnata; O'Connor, Siobhan; Earp, H. Shelton; Carey, Lisa A.; Perou, Charles M.; Savoldo, Barbara; Dotti, Gianpietro.png)
Share.png)
Save Clinical factors influencing retreatment with anti-PD-(L)1 therapies after treatment in early-stage cancers: a modified Delphi consensus studyPusztai, Lajos; Sondak, Vernon K.; Cappuzzo, Federico; Chouaid, Christos; Elder, Chris; Hirasawa, Yosuke; Ishida, Masaru; Jones, Robert; Lee, Seung Hyeun; Mizuno, Ryuichi; Nagata, Masayoshi; Okonji, David; Parente, Phillip; Shah, Bhavesh; Sun, Alexander; Ferreira, Dominihemberg; Spiteri, Carmel; Lauer, Andrea; Kaliasethi, Amrit; Kao, Carol; Kothari, Smita; Mckendrick, Jan Share Save Tislelizumab as adjuvant therapy following endoscopic surgery for resectable recurrent nasopharyngeal carcinoma: a randomized clinical trialLi, Wanpeng; Wang, Tian; Xu, Haoyuan; Liu, Quan; Zhang, Huankang; Yang, Yufei; Sun, Xicai; Yu, Huapeng; Gu, Yurong; Li, Houyong; Ding, Hao; Wang, Dehui Share Save IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against pancreatic cancer in mice with obesityTalele, Nilesh P.; Kumra, Heena; Gomes-Santos, Igor L.; Ho, William W.; Andersson, Patrik; Siwicki, Marie; Huang, Peigen; Duda, Dan G.; Pittet, Mikael J.; Fukumura, Dai; Jain, Rakesh K. Share Save Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trialBlanc, Jeremy; Carnot, Aurelien; Barthelemy, Philippe; Casert, Vinciane; Sautois, Brieuc; van den Brande, Jan; Vanhaudenarde, Vincent; Staudacher, Lionel; Seront, Emmanuel; Debien, Veronique; Ameye, Lieveke; Kotecki, Nuria; Rothe, Francoise; Rorive, Sandrine; Fantoni, Jean-Christophe; Tricard, Thibault; Roumeguere, Thierry; Awada, Ahmad; Chanza, Nieves Martinez Share Save Decoding resistance to immune checkpoint inhibitors in non-small cell lung cancer: a comprehensive analysis of plasma proteomics and therapeutic implicationsHarel, Michal; Dahan, Nili; Lahav, Coren; Jacob, Eyal; Elon, Yehonatan; Puzanov, Igor; Kelly, Ronan J.; Shaked, Yuval; Leibowitz, Raya; Carbone, David P.; Gandara, David R.; Dicker, Adam P. Share Save Blockade of CLEVER-1 restrains immune evasion and enhances anti-PD-1 immunotherapy in gastric cancerYu, Kuan; Cao, Yifan; Zhang, Zihao; Wang, Leihao; Gu, Yichao; Xu, Tianwei; Zhang, Xiaolei; Guo, Xinxin; Shen, Zhenbin; Qin, Jing Share Save INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clusteringHolay, Nisha; Yadav, Rashi; Ahn, Sae Jeong; Kasiewicz, Melissa J.; Polovina, Anya; Rolig, Annah S.; Staebler, Thi; Becklund, Bryan; Simons, Noah D.; Koguchi, Yoshinobu; Eckelman, Brendan P.; de Durana, Yaiza Diaz; Redmond, William L. Share Save Development and validation of a serum proteomic test for predicting patient outcomes in advanced non-small cell lung cancer treated with atezolizumab or docetaxelSrivastava, Minu K.; Zou, Wei; McCleland, Mark; Roder, Joanna; Asmellash, Senait; Norman, Patrick; Net, Lelia; Maguire, Laura; Roder, Heinrich; Georgantas, Robert; Shames, David S. Share Save Onboard, tethered IL-12 boosts potency of the Tmod NOT gate and preserves selectivityZhang, Jingli A.; Imboden, Sara; Lee, Dongwoo; Zampieri, Alexandre; Shafaattalab, Sanam; Liang, Jushen; Bruno, Richele; Torres, Jon; Partin, Alexander; Daris, Mark E.; Riley, Timothy P.; Kamb, Alexander Share Save 
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
